Rational design of diagnostic and vaccination strategies for tuberculosis

Rational design of diagnostic and vaccination strategies for tuberculosis

Show other versions (1)

The development of diagnostic tests which can readily differentiate between vaccinated and tuberculosis-infected individuals is crucial for the wider utilization of bacillus Calmette-Guérin (BCG) as vaccine in humans and animals. BCG_0092 is an antigen that elicits specific delayed type hypersensiti...

Full description

Bibliographic Details
Main Authors:	Sibele Borsuk, Fabiana Kommling Seixas, Daniela Fernandes Ramos, Tom Mendum, Johnjoe McFadden, Odir Dellagostin
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Subjects:	Gene knockout techniques Clinical diagnosis BCG vaccine
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702012000100012&lng=en&tlng=en

Similar Items

Rational design of diagnostic and vaccination strategies for tuberculosis
by: Sibele Borsuk, et al.
Published: (2012-01-01)

Features of the development of tuberculosis in children not vaccinated with BCG
by: O. M. Raznatovska, et al.
Published: (2018-07-01)

Contemporary aspects of tuberculosis in children without BCG vaccination
by: M. N. Kondаkovа, et al.
Published: (2021-04-01)

Vacina BCG contra tuberculose: efeito protetor e políticas de vacinação BCG vaccine against tuberculosis: its protective effect and vaccination policies
by: Susan M Pereira, et al.
Published: (2007-09-01)

Vaccination against M. tuberculosis – what next after BCG?
by: Marek Fol, et al.
Published: (2011-01-01)

BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4+ T Cells
by: Harindra D. Sathkumara, et al.
Published: (2019-03-01)

An Overview of the Development of New Vaccines for Tuberculosis
by: E. Whitlow, et al.
Published: (2020-10-01)

COVID-19 Infection and Previous BCG Vaccination Coverage in the Ecuadorian Population
by: Daniel Garzon-Chavez, et al.
Published: (2021-01-01)

Stable expression of Mycobacterium bovis antigen 85B in auxotrophic M. bovis bacillus Calmette-Guérin
by: Caroline Rizzi, et al.

Prevalence of Latent TB and Effectiveness of BCG Vaccination Against Latent Tuberculosis: An Observational Study
by: Birger Trollfors, MD, et al.
Published: (2021-08-01)

Vaccine research and development: tuberculosis as a global health threat
by: Mohammed Maikudi Usman, et al.
Published: (2017-08-01)

Results of the Monitoring for BCG Vaccination Complications
by: S.M. Liepshina, et al.
Published: (2015-02-01)

Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?
by: Renata Monteiro-Maia, et al.
Published: (2014-09-01)

Stable expression of Leptospira interrogans antigens in auxotrophic Mycobacterium bovis BCG
by: FABIANA K SEIXAS, et al.
Published: (2010-01-01)

TUBERCULOSIS VACCINES: CURRENT STATE AND FUTURE DIRECTIONS
by: Olimpia Nicolaescu
Published: (2017-03-01)

ON VACCINATION OF ADOLESCENTS AGAINST TUBERCULOSIS
by: L. A. Zazimko, et al.
Published: (2014-01-01)

Comparative assessment of tuberculosis vaccination in children with perinatal exposure to HIV and without it
by: V. A. Kukarkina, et al.
Published: (2020-10-01)

Difference in Severity of Tuberculosis in Children with or without a BCG Scar
by: Gunadi Santosa, et al.
Published: (2019-04-01)

COMPARATIVE ANALYSIS OF THE FREQUENCY AND STRUCTURE OF COMPLICATIONS OF THE BCG AND BCG-M TUBERCULOSIS VACCINE
by: Pozdnyakova A. S.
Published: (2021-03-01)

Sternal osteomyelitis after bacillus Calmette-Guérin vaccination
by: Rolandas Selvestravičius, et al.
Published: (2016-09-01)

Immune status of children with complications of BCG/BCG-M vaccination
by: T. A. Sevostyanova, et al.
Published: (2020-02-01)

Neonatal vaccination against tuberculosis under present-day conditions: Significance and problems
by: V. A. Aksenova, et al.
Published: (2016-03-01)

Integração das atividades de vacinação pelo BCG intradérmico nos programas gerais de imunização das unidades sanitárias Integration of intradermic BCG vaccination in general public health immunization programmes
by: Roberto Brólio, et al.
Published: (1976-03-01)

Vaccine Development Against Tuberculosis Over the Last 140 Years: Failure as Part of Success
by: Stefan H. E. Kaufmann, et al.
Published: (2021-10-01)

How to avoid the impact of environmental mycobacteria towards the efficacy of BCG vaccination against tuberculosis?
by: Om Parkash
Published: (2014-01-01)

Advances in the development of new vaccines against tuberculosis. 100 years after the introduction of BCG
by: Katarzyna Krysztopa-Grzybowska, et al.
Published: (2014-06-01)

PROTECTIVE EFFECT INDUCED BY THE NEW SUBUNIT TUBERCULOSIS VACCINE WHEN USED AS A BCG BOOST IS ASSOCIATED WITH INHIBITION OF MYCOBACTERIAL DISSEMINATION
by: V. V. Yeremeev, et al.
Published: (2019-07-01)

PROTECTIVE EFFECT INDUCED BY THE NEW SUBUNIT TUBERCULOSIS VACCINE WHEN USED AS A BCG BOOST IS ASSOCIATED WITH INHIBITION OF MYCOBACTERIAL DISSEMINATION
by: Vladimir Yeremeev, et al.
Published: (2019-03-01)

Cost-Effectiveness Analysis of BCG Vaccination against Tuberculosis in Indonesia: A Model-Based Study
by: Afifah Machlaurin, et al.
Published: (2020-11-01)

Bacillus Calmette-Guerin vaccine and bladder cancer incidence: Scoping literature review and preliminary analysis
by: Sabrina Trigo, et al.
Published: (2021-03-01)

Estimativa do risco de infecção tuberculosa em populações vacinadas pelo BCG Determining the risk of tuberculosis infection in BCG-vaccinated populations
by: Gilberto Ribeiro Arantes, et al.
Published: (1992-04-01)

BCG-SSI® vaccine-associated lymphadenitis: Incidence and management
by: Arnis Engelis, et al.
Published: (2016-01-01)

Evidence for the Effect of Vaccination on Host-Pathogen Interactions in a Murine Model of Pulmonary Tuberculosis by Mycobacterium tuberculosis
by: Zyanya Lucia Zatarain-Barrón, et al.
Published: (2020-05-01)

A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus
by: Fabián E. Díaz, et al.
Published: (2021-04-01)

Scientific Opinion on field trials for bovine tuberculosis vaccination
by: EFSA Panel on Animal Health and Welfare (AHAW)
Published: (2013-12-01)

Advances in the characterization of a proteol iposome derived from Mycobacterium bovis BCG as vaccine candidate against tuberculosis
by: Nadine Alvarez-Cabrera, et al.
Published: (2014-12-01)

Field evaluation of the efficacy of Mycobacterium bovis BCG vaccine against tuberculosis in goats
by: Enric Vidal, et al.
Published: (2017-08-01)

Current and Novel Approaches to Vaccine Development Against Tuberculosis
by: Mark eCayabyab, et al.
Published: (2012-12-01)

Ecografía Tímica de Niños con Infecciones Recurrentes
by: Leticia de la Caridad Christian López, et al.
Published: (1999-09-01)

Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype Antigen
by: Nicolas Bruffaerts, et al.
Published: (2014-03-01)